Non-invasive prenatal testing (NIPT) using cell-free DNA (cfDNA) offers numerous benefits
to pregnant women and their families. It also raises ethical, legal and social concerns …

Background Noninvasive prenatal testing (NIPT) provides important benefits yet raises
ethical concerns. We surveyed Canadian pregnant women and their partners to explore …

Objective As the use of non‐invasive prenatal testing (NIPT) increases, its benefits and
concerns are being examined through surveys, qualitative studies, and bioethical analysis …

Background The clinical introduction of non-invasive prenatal testing for fetal aneuploidies is
currently transforming the landscape of prenatal screening in many countries. Since it is …

Purpose This study explored the degree to which pregnant women in Korea made informed
choices regarding noninvasive prenatal testing (NIPT) and investigated factors influencing …

Down syndrome (Trisomy 21) is a mild to moderate intellectual disability. Historically, this
condition has been a primary target for prenatal testing. However, Down syndrome has not …

Following its introduction to the market in 2011, the rapid spread of noninvasive prenatal
testing (NIPT) was driven by commercial developers of the technology. The numerous …

Non-invasive prenatal testing (NIPT) is moving the goalposts for the detection of genetic
disorders such as Down Syndrome (DS). NIPT not only misses fewer cases than first …

The implementation of non-invasive prenatal screening (NIPS) in Canada will be affected by
legal norms. The law can shape physician behaviour, help to crystallize standards of care …

Background: There are few studies on the uptake of non-invasive prenatal screening, but
those available suggest substantial variation in uptake in the initial years in which it was …